GlassScript(8324) Azurion 7 M20
Payments companies reported to CMS as associated with (8324) Azurion 7 M20. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with (8324) Azurion 7 M20, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with (8324) Azurion 7 M20
These are the largest totals companies reported as associated with (8324) Azurion 7 M20. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Bradley Bohnstedt | Indianapolis, IN | Neurological Surgery | $1,095.31 |
| Andres Fajardo | Indianapolis, IN | Vascular Surgery | $1,095.30 |
| Luis Sanchez | Saint Louis, MO | Vascular Surgery | $851.96 |
| Zubair Ahmed | Fayetteville, AR | Interventional Cardiology | $604.71 |
| Atul Sharma | New York, NY | Cardiovascular Disease | $252.27 |
| Vijay Iyer | Amherst, NY | Cardiovascular Disease | $153.48 |
| Jasvindar Singh | Saint Louis, MO | Interventional Cardiology | $132.50 |
| Darren Schneider | Philadelphia, PA | Vascular Surgery | $117.59 |
| Ehtisham Mahmud | San Diego, CA | Interventional Cardiology | $112.68 |
| Ryan Reeves | San Diego, CA | Interventional Cardiology | $112.67 |
Prescribed (8324) Azurion 7 M20?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.